Unlock instant, AI-driven research and patent intelligence for your innovation.

Targeted modified and drug-loaded exosome as well as preparation method and application thereof

An exosome and loaded technology, which is applied in the field of target-modified and drug-loaded exosomes and its preparation, can solve the problem that neurotrophic factors cannot efficiently cross the blood-brain barrier, and there is no neurotrophic factor delivery method , short half-life of neurotrophic factors, etc., to reduce toxicity and other unintended effects, reduce nerve tissue damage, and promote concentration

Active Publication Date: 2021-11-23
BEIJING TIANTAN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, there are currently the following problems in the delivery of neurotrophic factors to nerve tissue receptor cells: (1) The neurotrophic factors given by conventional intravenous or subcutaneous injection methods cannot efficiently cross the blood-brain barrier, although viral vectors, neurotrophic factor genes Modified cells, nanocapsules, and hydrogels have been used as loading means for neurotrophic factors
However, there is currently no efficient delivery method for loading neurotrophic factors on nerve tissue
(2) The half-life of neurotrophic factors is relatively short. For example, the half-life of NGF administered exogenously via vein is only 2.3 hours in the body, and the half-life of NGF administered by subcutaneous injection is only 4.5 hours.
(3) Non-specific delivery will cause unexpected adverse effects on peripheral tissues, such as intramuscular injection of NGF will cause local pain
[0005] Even if the messenger RNA (mRNA) of neurotrophic factors is directly delivered by intravenous injection or subcutaneous injection, because the mRNA is extremely unstable and prone to rapid degradation, it is impossible to directly deliver the mRNA of neurotrophic factors to the nerve tissue and translate into neurotrophic factors

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Targeted modified and drug-loaded exosome as well as preparation method and application thereof
  • Targeted modified and drug-loaded exosome as well as preparation method and application thereof
  • Targeted modified and drug-loaded exosome as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Example 1. NGF@Exo RVG construction and identification of

[0052] In this application, we used the plasmid expressed by fusion of rabies virus glycoprotein (RVG) and exosomal protein lysosome-associated membrane glycoprotein 2b (Lamp2b) to carry out targeted modification on exosomes to prepare RVG-modified exosomes, and Neurotrophic factors and their mRNAs are loaded into the RVG-modified exosomes. In this example, the preparation process is described by taking the loading of the RVG-modified exosomes with human recombinant NGF protein and its mRNA as an example.

[0053] NGF@Exo RVG Construction of RVG and Lamp2b fusion expression plasmid pcDNA3.1(-)-RVG-Lamp2b (recorded in "Exosome Mediated Delivery of miR-124 Promotes Neurogenesis after Ischemia.", PMID: 28624203) and cloned neurotrophic factor The recombinant vector pCI-neo-NGF plasmid (CN 102898514 A) (in this application, RVG-Lamp2b+NGF will be used to represent these two plasmids) co-transfected human embryon...

Embodiment 2

[0057] Example 2. NGF@Exo RVG Contains NGF detection

[0058] qRT-PCR was used to detect the expression level of NGF mRNA in HEK293 cells without transfection, HEK293 cells co-transfected with RVG-Lamp2b+NGF, and HEK293 cells co-transfected with pcDNA3.1+pCI-neo. The results showed that co-transfection The level of NGF mRNA in HEK293 cells transfected with RVG-Lamp2b+NGF was significantly increased (see Figure 2A ).

[0059] qRT-PCR was used to detect exosomes harvested from the culture supernatant of untransfected HEK293 cells, HEK293 cells co-transfected with RVG-Lamp2b+NGF, and co-transfected with pcDNA3.1+pCI-neo HEK293 cells The expression level of NGFmRNA, the results show that the NGF@Exo harvested from the culture supernatant of HEK293 cells co-transfected with RVG-Lamp2b+NGF RVG The level of NGF mRNA was significantly increased (see Figure 2B ).

[0060]NGF protein in exosomes harvested from untransfected HEK293 cells, HEK293 cells co-transfected with RVG-Lamp2...

Embodiment 3

[0062] Example 3.NGF@Exo RVG Can deliver NGF to recipient cells

[0063] The aforementioned results prove that NGF@Exo RVG NGF mRNA and protein can be loaded, we also explored the exosome NGF@Exo RVG Whether NGF can be delivered to recipient cells when taken up by recipient cells. To this end, we added no or 20 μg, 50 μg, 100 μg, 200 μg or 300 μg of NGF@Exo to HEK293 cell culture medium RVG Incubate for 4h (eg Figure 3A shown). It was found by qRT-PCR detection without adding NGF@Exo RVG , HEK293 cells had no obvious expression of nerve growth factor; adding 100μg NGF@Exo RVG Can significantly increase the level of NGF mRNA in HEK293 recipient cells. With 20μg and 50μg NGF@Exo RVG After incubation, although nerve growth factor tended to increase, it did not significantly increase the expression of nerve growth factor mRNA; 100-300μg NGF@Exo RVG Can significantly increase NGF mRNA and protein levels in recipient cells HEK293, when 200μg and 300μg NGF@Exo RVG The incr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The embodiment of the invention relates to a targeted modified drug-loaded exosome as well as a preparation method and application thereof. The exosome is loaded with one or more of the following components: a neurotrophic factor, a neurotrophic factor fragment having neurotrophic factor activity, an oligopeptide having neurotrophic factor activity, and mRNA encoding the same, the exosome can deliver the neurotrophic factor to nerve tissue recipient cells in a targeted manner, thereby reduce nerve tissue damage and promote repair by means of anti-inflammation, anti-apoptosis, promotion of nerve cell survival and promotion of nerve regeneration. In addition, the exosome can be stably stored at -80 DEG C for 3 months, and the preparation method is simple.

Description

technical field [0001] The present invention relates to the field of biotechnology, in particular to an exosome that is targetedly modified and loaded with drugs and its preparation method and application. Background technique [0002] The incidence of ischemic stroke, hemorrhagic stroke, Alzheimer's disease, Parkinson's disease and other neurological diseases is increasing in modern society, and the treatment is difficult. Taking acute ischemic stroke as an example, the only FDA-approved drug is rt-PA, but its treatment time window is only 4.5 hours, resulting in only a small number of patients benefiting from it, so it is urgent to develop therapeutic drugs. [0003] The neurotrophic factor family includes nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophic factor 4 (NT4), neurotrophic factor 5 (NT5) and the like. NGF is the first discovered molecule of the neurotrophic factor family, which plays a key regulatory role in the physiological dev...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K47/64A61K47/54A61K38/18A61P25/00A61P9/10A61P7/04A61P25/28A61P25/14A61P27/02A61P25/16A61P25/02A61P7/10A61P21/04A61P21/00A61P3/10A61P5/00A61P29/00C12N5/10C12N15/62C12N15/85
CPCA61K47/64A61K47/549A61K38/185A61P25/00A61P9/10A61P7/04A61P25/28A61P25/14A61P27/02A61P25/16A61P25/02A61P7/10A61P21/04A61P21/00A61P3/10A61P5/00A61P29/00C07K14/005C07K14/475C07K14/47C12N15/85C07K2319/00C12N2760/20122A61K38/18A61K47/54C12N5/10C12N15/62A61K38/00C12N15/63
Inventor 杨佳蕾王拥军杨国栋吴诗坡侯丽华
Owner BEIJING TIANTAN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV